scholarly article | Q13442814 |
P356 | DOI | 10.2337/DC16-0383 |
P698 | PubMed publication ID | 27519448 |
P50 | author | Alan D. Cherrington | Q60573078 |
Harith Rajagopalan | Q88116508 | ||
P2093 | author name string | Lee M Kaplan | |
Christopher C Thompson | |||
Francesco Rubino | |||
Geltrude Mingrone | |||
Pablo Becerra | |||
Patricia Rodriguez | |||
Manoel P Galvao Neto | |||
Leonardo Rodriguez | |||
Jay Caplan | |||
Paulina Vignolo | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
P304 | page(s) | 2254-2261 | |
P577 | publication date | 2016-08-12 | |
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study | |
P478 | volume | 39 |
Q48317296 | A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity. |
Q46084030 | ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management |
Q61905346 | ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management |
Q61905355 | ASGE EndoVators Summit: defining the role and value of endoscopic therapies in obesity management |
Q47256071 | Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss |
Q90465244 | Current and Future Endoscopic Weight Loss Solutions |
Q52581465 | Devices and Endoscopic Bariatric Therapies for Obesity. |
Q50075045 | Diabetes and the Small Intestine |
Q55071381 | Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites. |
Q41999658 | Endoluminal weight loss and metabolic therapies: current and future techniques |
Q33811372 | Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic Procedures |
Q88673275 | Endoscopic Interventions in the Treatment of Obesity and Diabetes |
Q49899718 | Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes |
Q47891302 | Endoscopic Treatments for Obesity. |
Q92090714 | Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study |
Q89624077 | Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results |
Q92068499 | Endoscopic intragastric balloon: a gimmick or a viable option for obesity? |
Q64067771 | Histologic assessment of the intestinal wall following duodenal mucosal resurfacing (DMR): a new procedure for the treatment of insulin-resistant metabolic disease |
Q88312453 | Latest Developments and Future Perspectives in the Field Of Obesity |
Q39429642 | Medical devices for the treatment of obesity |
Q99610102 | Overview of bariatric and metabolic endoscopy interventions |
Q37633943 | Recent Clinical Results of Endoscopic Bariatric Therapies as an Obesity Intervention |
Q37633938 | Recent Trends in Endoscopic Bariatric Therapies |
Q92544525 | Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device |
Q59127264 | Small Bowel Endoscopic Bariatric Therapies |
Q53438835 | The Science of Obesity Management: An Endocrine Society Scientific Statement. |
Q89624069 | The changing face of hepatology |
Q94093775 | UEG Week 2018 Poster Presentations |
Q57146078 | Updated panel report: best practices for the surgical treatment of obesity |